Deakin University
Browse
khasraw-immunethrombocytopenic-2009.pdf (37.27 kB)

Immune thrombocytopenic purpura (ITP) and breast cancer. Does adjuvant therapy for breast cancer improve platelet counts in ITP?

Download (37.27 kB)
journal contribution
posted on 2009-01-01, 00:00 authored by Mustafa Khasraw, S Baron-Hay
Although both breast cancer and immune thrombocytopenic purpura (ITP) are common conditions, the simultaneous coexistence of these two diseases is rare. ITP is an autoimmune disease in which the presence of autoantibodies against platelets results in splenic sequestration and thrombocytopenia that may be associated with lymphoid neoplasms [1]. Except for an observational case series of 10 patients [2], only a few individual case reports of ITP coinciding with breast cancer have been reported [3–8]. We are reporting two cases with simultaneous confirmed ITP and breast cancer. The platelet counts in both women have improved during adjuvant breast cancer chemotherapy.

History

Journal

Annals of oncology

Volume

20

Issue

7

Pagination

1282 - 1283

Publisher

Oxford University Press

Location

Oxford, England

ISSN

0923-7534

eISSN

1569-8041

Language

eng

Publication classification

C4.1 Letter or note